Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: protocol of a multicentre randomised controlled trial
Introduction Optimal glycaemic control is beneficial to prevent and delay microvascular complications in patients with type 1 diabetes mellitus (T1DM). The benefits of flash glucose monitoring (FGM) have been proved among well-controlled adults with T1DM, but evidence for FGM in adults with T1DM who...
Main Authors: | Yongwen Zhou, Hongrong Deng, Hongxia Liu, Daizhi Yang, Wen Xu, Bin Yao, Jinhua Yan, Jianping Weng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-12-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/12/e039400.full |
Similar Items
-
Flash glucose monitoring in gestational diabetes mellitus: study protocol for a randomised controlled trial
by: Agata Majewska, et al.
Published: (2021-03-01) -
Effect of 6 months’ flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a ‘flash’ randomised controlled trial protocol
by: Sara E. Boucher, et al.
Published: (2019-05-01) -
Effectiveness of real-time continuous glucose monitoring to improve glycaemic control and pregnancy outcome in patients with gestational diabetes mellitus: a study protocol for a randomised controlled trial
by: Andrea Icks, et al.
Published: (2020-11-01) -
Impacts of glycemic variability on the relationship between glucose management indicator from iPro2 and laboratory hemoglobin A1c in adult patients with type 1 diabetes mellitus
by: Hongxia Liu, et al.
Published: (2020-06-01) -
Evaluating the Effect of Cabergoline on Glycaemic Control of Patients with Type 2 Diabetes Mellitus: A Randomised Controlled Trial
by: Akbar AliAsgarzadeh, et al.
Published: (2020-02-01)